A Global MicroRNA Profile in Fanconi Anemia: A Pilot Study

Paolo Degan, Enrico Cappelli, Maria Grazia Longobardi, Alessandra Pulliero, Paola Cuccarolo, Carlo Dufour, Silvia Ravera, Daniela Calzia, Alberto Izzotti

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: Fanconi anemia (FA) is a complex tumor-prone disease defined by an entangled genotype and phenotype. Despite enormous efforts in the last 20 years, a comprehensive and integrated view of the disease is still missing. The aim of this pilot study was to establish whether a global microRNA (miRNA) analysis approach could be helpful in defining aspects in FA phenotype, which might deserve future attention with the perspective to develop miRNA-based therapies. Methods: miRNA array were employed to characterize the global miRNA (miRNoma) profile of FA RNA samples with respect to normal samples. Results: We report and compare miRNA profile from two FA established cell lines and three FA patients. This analysis reveals that 36 and 64 miRNAs, respectively, are found differentially expressed (>2-fold variation and P < 0.05) in the samples from FA cell lines and FA patients. Overlap of these data results in 24 miRNAs as shared in the two sample populations. Available bioinformatics methods were used to predict target genes for the differentially expressed miRNAs and to perform pathway enrichment analysis. Conclusions: Seven pathway results associated with the FA phenotype. It is interesting to note that some of these pathways were previously unrelated to FA phenotype. It might be important to focus on these pathways not previously emerged as dysfunctional in FA to better define the pathophysiological context of this disease. This is the first report of a global miRNA analysis in FA.

Original languageEnglish
Pages (from-to)53-59
Number of pages7
JournalMetabolic Syndrome and Related Disorders
Volume17
Issue number1
DOIs
Publication statusPublished - Feb 1 2019

Fingerprint

Fanconi Anemia
MicroRNAs
Phenotype
Cell Line
Computational Biology
Genotype

Keywords

  • cancer-prone diseases
  • data mining
  • Fanconi anemia
  • KEGG pathways
  • metabolic relationships
  • microRNA

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

A Global MicroRNA Profile in Fanconi Anemia : A Pilot Study. / Degan, Paolo; Cappelli, Enrico; Longobardi, Maria Grazia; Pulliero, Alessandra; Cuccarolo, Paola; Dufour, Carlo; Ravera, Silvia; Calzia, Daniela; Izzotti, Alberto.

In: Metabolic Syndrome and Related Disorders, Vol. 17, No. 1, 01.02.2019, p. 53-59.

Research output: Contribution to journalArticle

Degan, Paolo ; Cappelli, Enrico ; Longobardi, Maria Grazia ; Pulliero, Alessandra ; Cuccarolo, Paola ; Dufour, Carlo ; Ravera, Silvia ; Calzia, Daniela ; Izzotti, Alberto. / A Global MicroRNA Profile in Fanconi Anemia : A Pilot Study. In: Metabolic Syndrome and Related Disorders. 2019 ; Vol. 17, No. 1. pp. 53-59.
@article{3f693424f6d44d4a8e5961e860b23769,
title = "A Global MicroRNA Profile in Fanconi Anemia: A Pilot Study",
abstract = "Purpose: Fanconi anemia (FA) is a complex tumor-prone disease defined by an entangled genotype and phenotype. Despite enormous efforts in the last 20 years, a comprehensive and integrated view of the disease is still missing. The aim of this pilot study was to establish whether a global microRNA (miRNA) analysis approach could be helpful in defining aspects in FA phenotype, which might deserve future attention with the perspective to develop miRNA-based therapies. Methods: miRNA array were employed to characterize the global miRNA (miRNoma) profile of FA RNA samples with respect to normal samples. Results: We report and compare miRNA profile from two FA established cell lines and three FA patients. This analysis reveals that 36 and 64 miRNAs, respectively, are found differentially expressed (>2-fold variation and P < 0.05) in the samples from FA cell lines and FA patients. Overlap of these data results in 24 miRNAs as shared in the two sample populations. Available bioinformatics methods were used to predict target genes for the differentially expressed miRNAs and to perform pathway enrichment analysis. Conclusions: Seven pathway results associated with the FA phenotype. It is interesting to note that some of these pathways were previously unrelated to FA phenotype. It might be important to focus on these pathways not previously emerged as dysfunctional in FA to better define the pathophysiological context of this disease. This is the first report of a global miRNA analysis in FA.",
keywords = "cancer-prone diseases, data mining, Fanconi anemia, KEGG pathways, metabolic relationships, microRNA",
author = "Paolo Degan and Enrico Cappelli and Longobardi, {Maria Grazia} and Alessandra Pulliero and Paola Cuccarolo and Carlo Dufour and Silvia Ravera and Daniela Calzia and Alberto Izzotti",
year = "2019",
month = "2",
day = "1",
doi = "10.1089/met.2018.0085",
language = "English",
volume = "17",
pages = "53--59",
journal = "Metabolic Syndrome and Related Disorders",
issn = "1540-4196",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - A Global MicroRNA Profile in Fanconi Anemia

T2 - A Pilot Study

AU - Degan, Paolo

AU - Cappelli, Enrico

AU - Longobardi, Maria Grazia

AU - Pulliero, Alessandra

AU - Cuccarolo, Paola

AU - Dufour, Carlo

AU - Ravera, Silvia

AU - Calzia, Daniela

AU - Izzotti, Alberto

PY - 2019/2/1

Y1 - 2019/2/1

N2 - Purpose: Fanconi anemia (FA) is a complex tumor-prone disease defined by an entangled genotype and phenotype. Despite enormous efforts in the last 20 years, a comprehensive and integrated view of the disease is still missing. The aim of this pilot study was to establish whether a global microRNA (miRNA) analysis approach could be helpful in defining aspects in FA phenotype, which might deserve future attention with the perspective to develop miRNA-based therapies. Methods: miRNA array were employed to characterize the global miRNA (miRNoma) profile of FA RNA samples with respect to normal samples. Results: We report and compare miRNA profile from two FA established cell lines and three FA patients. This analysis reveals that 36 and 64 miRNAs, respectively, are found differentially expressed (>2-fold variation and P < 0.05) in the samples from FA cell lines and FA patients. Overlap of these data results in 24 miRNAs as shared in the two sample populations. Available bioinformatics methods were used to predict target genes for the differentially expressed miRNAs and to perform pathway enrichment analysis. Conclusions: Seven pathway results associated with the FA phenotype. It is interesting to note that some of these pathways were previously unrelated to FA phenotype. It might be important to focus on these pathways not previously emerged as dysfunctional in FA to better define the pathophysiological context of this disease. This is the first report of a global miRNA analysis in FA.

AB - Purpose: Fanconi anemia (FA) is a complex tumor-prone disease defined by an entangled genotype and phenotype. Despite enormous efforts in the last 20 years, a comprehensive and integrated view of the disease is still missing. The aim of this pilot study was to establish whether a global microRNA (miRNA) analysis approach could be helpful in defining aspects in FA phenotype, which might deserve future attention with the perspective to develop miRNA-based therapies. Methods: miRNA array were employed to characterize the global miRNA (miRNoma) profile of FA RNA samples with respect to normal samples. Results: We report and compare miRNA profile from two FA established cell lines and three FA patients. This analysis reveals that 36 and 64 miRNAs, respectively, are found differentially expressed (>2-fold variation and P < 0.05) in the samples from FA cell lines and FA patients. Overlap of these data results in 24 miRNAs as shared in the two sample populations. Available bioinformatics methods were used to predict target genes for the differentially expressed miRNAs and to perform pathway enrichment analysis. Conclusions: Seven pathway results associated with the FA phenotype. It is interesting to note that some of these pathways were previously unrelated to FA phenotype. It might be important to focus on these pathways not previously emerged as dysfunctional in FA to better define the pathophysiological context of this disease. This is the first report of a global miRNA analysis in FA.

KW - cancer-prone diseases

KW - data mining

KW - Fanconi anemia

KW - KEGG pathways

KW - metabolic relationships

KW - microRNA

UR - http://www.scopus.com/inward/record.url?scp=85061084325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061084325&partnerID=8YFLogxK

U2 - 10.1089/met.2018.0085

DO - 10.1089/met.2018.0085

M3 - Article

C2 - 30376422

AN - SCOPUS:85061084325

VL - 17

SP - 53

EP - 59

JO - Metabolic Syndrome and Related Disorders

JF - Metabolic Syndrome and Related Disorders

SN - 1540-4196

IS - 1

ER -